Orion Capital Management’s Lockheed Martin LMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$471K Buy
780
+55
+8% +$33.9K 0.16% 85
2025
Q4
$351K Sell
725
-17
-2% -$8.14K 0.12% 104
2025
Q3
$370K Buy
742
+2
+0.3% +$907 0.13% 101
2025
Q2
$343K Buy
740
+12
+2% +$5.62K 0.13% 94
2025
Q1
$325K Buy
728
+544
+296% +$250K 0.14% 94
2024
Q4
$89.4K Buy
+184
New +$100K 0.04% 179
2024
Q3
Sell
-184
Closed -$85.9K 301
2024
Q2
$85.9K Hold
184
0.05% 167
2024
Q1
$83.7K Hold
184
0.04% 183
2023
Q4
$83.4K Hold
184
0.05% 185
2023
Q3
$75.2K Buy
+184
New +$81.6K 0.05% 183
2023
Q2
Sell
-177
Closed -$83.7K 311
2023
Q1
$83.7K Hold
177
0.06% 173
2022
Q4
$86.1K Hold
177
0.06% 158
2022
Q3
$68K Buy
177
+115
+185% +$48K 0.05% 173
2022
Q2
$27K Hold
62
0.02% 242
2022
Q1
$27K Hold
62
0.02% 249
2021
Q4
$22K Hold
62
0.01% 247
2021
Q3
$21K Hold
62
0.01% 243
2021
Q2
$23K Hold
62
0.01% 221
2021
Q1
$23K Hold
62
0.02% 212
2020
Q4
$22K Buy
+62
New +$22.8K 0.02% 206

Other funds holding LMT

Orion Capital Management's LMT Position: Q1 2026 in Review

Orion Capital Management increased its Lockheed Martin (LMT) stake by 7.6% in Q1 2026, buying an estimated $33.9K and bringing the position to 780 shares worth $471K. The position accounts for 0.16% of the portfolio, ranked #85.

Orion Capital Management first reported a position in LMT in Q4 2020 and has held it in 20 quarters since. 2,910 funds tracked by Wall St. Rank hold LMT as of Q1 2026.

  • Orion Capital Management held 780 shares of Lockheed Martin worth $471K as of Q1 2026.
  • Orion Capital Management bought 55 Lockheed Martin shares in Q1 2026, an estimated $33.9K.
  • Lockheed Martin made up 0.16% of Orion Capital Management's portfolio in Q1 2026, its #85 holding.
  • Orion Capital Management first reported a position in Lockheed Martin in Q4 2020 and has held it in 20 quarters since.
  • 2,910 funds tracked by Wall St. Rank held Lockheed Martin as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.